Poly Medicure sees strong H1 FY26 growth, driven by acquisitions and domestic push

Poly Medicure Limited reported consolidated revenue of INR 847 crores for H1 FY26, a 5.3% year-on-year growth. Gross profit reached INR 584 crores, with a gross margin of 69%, an increase of 137 bps compared to last year. Operating EBITDA for H1 stood at INR 226 crores, translating to an operating EBITDA margin of 26.7%. Profit after tax totaled INR 185 crores, representing a 14.5% year-on-year growth and a net margin of 20%. The company expects overall revenue growth for FY26 to be between 15%-16%.

The company announced the acquisition of Italy-based Citieffe Group and Netherlands-based PendraCare Group in Q2 FY26. These acquisitions are expected to add approximately INR 280 crores to annual revenue. Domestic revenue grew by 17%-18% year-on-year, with a target of 28%-30% growth for FY26. International business showed a 9.1% quarter-on-quarter growth in Q2 FY26, with revenue of around INR 300 crores. CAPEX for H1 was INR 150 crores, with a planned total of over INR 250 crores for the full financial year to expand facilities.